MRI 유도 신경외과 절제 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

MRI Guided Neurosurgical Ablation Market Size, Share & Trends Analysis Report By Product (MRI Guided RF Ablation Systems, MRI Guided Laser Ablation Systems), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,609,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,950 ￦ 10,055,000

Printable PDF (5-User License)

PDF 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,950 ￦ 12,949,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

MRI 유도 신경외과 절제 시장의 성장과 트렌드

Grand View Research, Inc.의 최신 보고서에 따르면, MRI 유도 신경외과 절제술 세계 시장 규모는 2030년까지 11억 달러에 달할 것으로 예상되며, 2025-2030년까지 연평균 7.7%의 CAGR로 확대될 것으로 예상됩니다. 뇌종양을 포함한 신경질환을 앓고 있는 환자의 증가, 뇌질환 진단 및 치료에 대한 인식의 증가가 시장을 주도하고 있습니다.

뇌종양 유병률의 증가는 시장을 이끄는 주요 요인 중 하나입니다. 뇌 및 중추신경계 암은 120가지 이상의 종류가 있습니다. 미국 국립보건원(NIH)의 자료에 따르면, 2020년에는 미국에서 23,890명이 뇌종양 및 기타 신경계 암으로 새로 진단받은 것으로 추정됩니다. 따라서 뇌종양 발병률의 증가는 MRI 유도 신경외과 절제에 대한 수요를 증가시켜 시장 성장을 견인하고 있습니다.

치료 관련 기술의 발전이 시장 수요를 자극하고 있습니다. 예를 들어, Medtronic이 개발한 Visualase MRI 유도 레이저 소작 장비는 1.65mm의 가장 작은 레이저 카테터를 가지고 있으며, 실시간으로 조직 소작을 모니터링할 수 있습니다. 그 결과, 작은 절개로 환자의 회복을 앞당길 수 있습니다. 이는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

또한, 시장 진입 기업들의 다양한 인식 제고 캠페인, 신제품 출시, 신기술 도입은 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2019년 7월 Insightec은 외과적 절개 없이 신경 장애 치료를 위한 Exablate Neuro-초음파 플랫폼에 대한 FDA 승인 및 CE 마크를 획득했습니다.

MRI 유도 신경외과 절제 시장 보고서 하이라이트

• 제품별로는 액세서리 부문이 2024년 32.1%의 점유율로 전체 시장을 지배했습니다. 신경외과 수술 중 환자의 안전을 보장하기 위한 조작성, 기능성, 정확성 등 액세서리 부문이 제공하는 다양한 이점이 이 부문의 성장에 기여하고 있습니다.
• 최종 용도별로는 병원 부문이 2024년 65.4%의 점유율을 차지하며 전체 시장을 장악했습니다. 또한, 뇌 관련 수술은 가장 중요하고 복잡한 수술 중 하나이며, 병원에 있는 고품질의 내구성 있는 장비와 기기에 의존하고 있습니다.
• 북미는 잘 구축된 의료 시설의 존재, 뇌종양 발병률의 증가, 최신 치료법을 이용할 수 있는 지역으로 2024년 매출 점유율 35.0%를 차지하며 시장을 주도하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 MRI 유도 신경외과 절제 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 MRI 유도 신경외과 절제 시장 : 제품 비즈니스 분석

• 제품 시장 점유율, 2024년과 2030년
• 제품 부문 대시보드
• 시장 규모와 예측과 동향 분석, 제품별, 2018-2030년
• MRI 가이드 RF 절제 시스템
• MRI 가이드 레이저 절제 시스템
• MRI 가이드 집속 초음파 시스템
• 부속품

제5장 MRI 유도 신경외과 절제 시장 : 최종 용도 비즈니스 분석

• 최종 용도 시장 점유율, 2024년과 2030년
• 최종 용도 부문 대시보드
• 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
• 병원
• 클리닉
• 외래 수술 센터

제6장 MRI 유도 신경외과 절제 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 국가별, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 참여자 개요
• 기업의 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 개요/상장 기업
  • Siemens Healthineers AG
  • Monteris
  • Profound Medica
  • Insightec
  • Medtronic
  • Boston Scientific Corporation
  • AngioDynamics
  • ClearPoint Neuro, Inc.
  • Elekta
  • Accuray Incorporated

ksm

영문 목차

영문목차

MRI Guided Neurosurgical Ablation Market Growth & Trends:

The global MRI guided neurosurgical ablation market size is estimated to reach USD 1.1 billion by 2030, expanding at a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from neurological diseases, including brain tumors, and rising awareness initiatives for brain disorders diagnosis and treatment are driving the market.

Rising prevalence of brain cancer is one of the major factors driving the market. There are over 120 types of brain and central nervous system cancers. According to the National Institute of Health (NIH) data, it is estimated that in 2020, 23,890 people will be diagnosed with new cases of brain and other nervous system cancer in the U.S. Therefore, increasing incidence of brain cancer has increased the demand for MRI-guided neurosurgical ablation, thus boosting the market growth.

Technological advancements associated with the treatment are stimulating the demand in the market. For instance, a Visualase MRI-guided laser ablation device developed by Medtronic has the smallest laser catheter of 1.65 mm that monitors tissue ablation in real-time. As a result, it helps patients recover faster with a small incision. This is anticipated to boost the market growth over the forecast period.

Furthermore, several awareness campaigns, the introduction of new products, and incorporation of new technologies by market players are likely to boost the market growth during the forecast period. For instance, in July 2019, Insightec has received FDA approval and CE mark for the Exablate Neuro- ultrasound platform for the treatment of neurological disorders with no surgical incisions.

MRI Guided Neurosurgical Ablation Market Report Highlights:

• On the basis of product, the accessories segment dominated the overall market with a share of 32.1% in 2024. Numerous benefits offered by the accessories segment such as maneuverability, functionality, and precision to ensure patient safety during neurosurgical procedures are contributing towards the segment growth
• Based on end-use, the hospital segment dominated the overall market with a share of 65.4% in 2024 owing to high patients' preference to visit hospitals for the treatment. Moreover, brain-related procedures are among the most critical and complex surgeries that are reliant on high quality and durable devices and equipment found in hospitals
• North America dominated the market with a revenue share of 35.0% in 2024 owing to the presence of well-established healthcare facilities, increasing incidences of brain tumors, and the availability of the latest treatment procedures in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. MRI Guided Neurosurgical Ablation Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. MRI Guided Neurosurgical Ablation Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. MRI Guided RF Ablation Systems
  • 4.4.1. MRI Guided RF Ablation Systems Market, 2018 - 2030 (USD Million)
• 4.5. MRI Guided Laser Ablation Systems
  • 4.5.1. MRI Guided Laser Ablation Systems Market, 2018 - 2030 (USD Million)
• 4.6. MRI Guided Focused Ultrasound Systems
  • 4.6.1. MRI Guided Focused Ultrasound Systems Market, 2018 - 2030 (USD Million)
• 4.7. Accessories
  • 4.7.1. Accessories Market, 2018 - 2030 (USD Million)

Chapter 5. MRI Guided Neurosurgical Ablation Market: End Use Business Analysis

• 5.1. End Use Market Share, 2024 & 2030
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 5.5. Clinics
  • 5.5.1. Clinics Market, 2018 - 2030 (USD Million)
• 5.6. Ambulatory Surgical Centers
  • 5.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)

Chapter 6. MRI Guided Neurosurgical Ablation Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait MRI Guided Neurosurgical Ablation Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Siemens Healthineers AG
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Monteris
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Profound Medica
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Insightec
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Medtronic
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Boston Scientific Corporation
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. AngioDynamics
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. ClearPoint Neuro, Inc.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Elekta
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Accuray Incorporated
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives

관련자료